Further investigation into the cathepsin–cystatin balance, along with exploration of lncRNA and gene regulatory pathways, may yield novel strategies for modifying disease progression in ALS; the therapeutic potential of cathepsins in ALS is summarized in Table 5. Here, CST4 is linked to amyotrophic lateral sclerosis.